BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 26418951)

  • 21. Cytokine-induced killer (CIK) cells bound with anti-CD3/anti-CD133 bispecific antibodies target CD133(high) cancer stem cells in vitro and in vivo.
    Huang J; Li C; Wang Y; Lv H; Guo Y; Dai H; Wicha MS; Chang AE; Li Q
    Clin Immunol; 2013 Oct; 149(1):156-68. PubMed ID: 23994769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coculturing dendritic cells with zoledronate acid efficiently enhance the anti-tumor effects of cytokine-induced killer cells.
    Su X; Zhang L; Jin L; Ye J; Guan Z; Chen R
    J Clin Immunol; 2010 Sep; 30(5):766-74. PubMed ID: 20549316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Natural killer cell-based adoptive immunotherapy eradicates and drives differentiation of chemoresistant bladder cancer stem-like cells.
    Ferreira-Teixeira M; Paiva-Oliveira D; Parada B; Alves V; Sousa V; Chijioke O; Münz C; Reis F; Rodrigues-Santos P; Gomes C
    BMC Med; 2016 Oct; 14(1):163. PubMed ID: 27769244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic effect of cytokine-induced killer cell with valproate inhibits growth of hepatocellular carcinoma cell in a mouse model.
    Lee DH; Nam JY; Chang Y; Cho H; Kang SH; Cho YY; Cho E; Lee JH; Yu SJ; Kim YJ; Yoon JH
    Cancer Biol Ther; 2017 Jan; 18(1):67-75. PubMed ID: 28055304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Roles of NKG2D in cytokine-induced killer (CIK) against hematological malignant cells lines].
    He JY; Jia ZX; Cai XH; Han WM; Xiao R; Ma LD; Lu XZ; Zhou M; Chen BA
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec; 21(6):1380-4. PubMed ID: 24370015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NKG2D Engagement Alone Is Sufficient to Activate Cytokine-Induced Killer Cells While 2B4 Only Provides Limited Coactivation.
    Wu X; Sharma A; Oldenburg J; Weiher H; Essler M; Skowasch D; Schmidt-Wolf IGH
    Front Immunol; 2021; 12():731767. PubMed ID: 34691037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD44+ cancer stem-like cells in EBV-associated nasopharyngeal carcinoma.
    Lun SW; Cheung ST; Cheung PF; To KF; Woo JK; Choy KW; Chow C; Cheung CC; Chung GT; Cheng AS; Ko CW; Tsao SW; Busson P; Ng MH; Lo KW
    PLoS One; 2012; 7(12):e52426. PubMed ID: 23285037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Pinx1 Gene Downregulates Telomerase and Inhibits Proliferation of CD133+ Cancer Stem Cells Isolated from a Nasopharyngeal Carcinoma Cell Line by Regulating Trfs and Mad1/C-Myc/p53 Pathways.
    Shen C; Chen F; Wang H; Li G; Yu C; Wang X; Wen Z
    Cell Physiol Biochem; 2018; 49(1):282-294. PubMed ID: 30138944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of the Expression of Surface Receptors on NK Cells and NKG2D on Immunocytes in Peripheral Blood of Patients with Nasopharyngeal Carcinoma.
    Xu Y; Zhou R; Huang C; Zhang M; Li J; Zong J; Qiu S; Lin S; Chen H; Ye Y; Pan J
    Asian Pac J Cancer Prev; 2018 Mar; 19(3):661-665. PubMed ID: 29580037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytokines for the induction of antitumor effectors: The paradigm of Cytokine-Induced Killer (CIK) cells.
    Cappuzzello E; Sommaggio R; Zanovello P; Rosato A
    Cytokine Growth Factor Rev; 2017 Aug; 36():99-105. PubMed ID: 28629761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone marrow mesenchymal stem cells reduce the antitumor activity of cytokine-induced killer/natural killer cells in K562 NOD/SCID mice.
    Li Y; Qu YH; Wu YF; Wang XP; Wei J; Huang WG; Zhou DH; Fang J; Huang K; Huang SL
    Ann Hematol; 2011 Aug; 90(8):873-85. PubMed ID: 21234566
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implication of combined PD-L1/PD-1 blockade with cytokine-induced killer cells as a synergistic immunotherapy for gastrointestinal cancer.
    Dai C; Lin F; Geng R; Ge X; Tang W; Chang J; Wu Z; Liu X; Lin Y; Zhang Z; Li J
    Oncotarget; 2016 Mar; 7(9):10332-44. PubMed ID: 26871284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytokine-induced killer cells hunt individual cancer cells in droves in a mouse model.
    Kim JS; Kim YG; Lee HK; Park EJ; Kim B; Kang JS; Lee H; Kim Y; Hong JT; Han SB
    Cancer Immunol Immunother; 2017 Feb; 66(2):193-202. PubMed ID: 27888293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Downregulation of Bmi-1 is associated with suppressed tumorigenesis and induced apoptosis in CD44⁺ nasopharyngeal carcinoma cancer stem-like cells.
    Xu X; Liu Y; Su J; Li D; Hu J; Huang Q; Lu M; Liu X; Ren J; Chen W; Sun L
    Oncol Rep; 2016 Feb; 35(2):923-31. PubMed ID: 26573774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin-15-transferred cytokine-induced killer cells elevated anti-tumor activity in a gastric tumor-bearing nude mice model.
    Peng Z; Liang W; Li Z; Xu Y; Chen L
    Cell Biol Int; 2016 Feb; 40(2):204-13. PubMed ID: 26503216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Crucifera sulforaphane (SFN) inhibits the growth of nasopharyngeal carcinoma through DNA methyltransferase 1 (DNMT1)/Wnt inhibitory factor 1 (WIF1) axis.
    Chen L; Chan LS; Lung HL; Yip TTC; Ngan RKC; Wong JWC; Lo KW; Ng WT; Lee AWM; Tsao GSW; Lung ML; Mak NK
    Phytomedicine; 2019 Oct; 63():153058. PubMed ID: 31394414
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytokine-induced killer cells as immunotherapy for solid tumors: current evidence and perspectives.
    Giraudo L; Gammaitoni L; Cangemi M; Rotolo R; Aglietta M; Sangiolo D
    Immunotherapy; 2015; 7(9):999-1010. PubMed ID: 26310715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DC-CIK cells derived from ovarian cancer patient menstrual blood activate the TNFR1-ASK1-AIP1 pathway to kill autologous ovarian cancer stem cells.
    Qin W; Xiong Y; Chen J; Huang Y; Liu T
    J Cell Mol Med; 2018 Jul; 22(7):3364-3376. PubMed ID: 29566310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Memory T Cells Expressing an NKG2D-CAR Efficiently Target Osteosarcoma Cells.
    Fernández L; Metais JY; Escudero A; Vela M; Valentín J; Vallcorba I; Leivas A; Torres J; Valeri A; Patiño-García A; Martínez J; Leung W; Pérez-Martínez A
    Clin Cancer Res; 2017 Oct; 23(19):5824-5835. PubMed ID: 28659311
    [No Abstract]   [Full Text] [Related]  

  • 40. Combining antiangiogenic therapy with adoptive cell immunotherapy exerts better antitumor effects in non-small cell lung cancer models.
    Shi S; Wang R; Chen Y; Song H; Chen L; Huang G
    PLoS One; 2013; 8(6):e65757. PubMed ID: 23799045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.